Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Show me how to use this page

Evotec AG Stock

Watchlist
Price
Target price
€29.55

€29.55

-3.790%
-1.0
-3.790%
€37.00

€37.00

 
Buy 29 Sell 3
Buy 29
Sell 3
05.03.21 / Tradegate WKN: 566480 / Name: Evotec / Stock / Biotechnology & Medical Research / Mid Cap
Latest predictions
€40.00
20.01.21
buy
-
19.01.21
buy
-
07.01.21
sell
€40.00
06.01.21
buy
-
01.01.21
buy
€45.00
30.12.20
buy
Your prediction
Pros and Cons of Evotec AG in the next few years
Wizard

Evotec AG Stock

Evotec AG took a tumble today and lost -€1.000 (-3.790%).
The stock is one of the favorites of our community with 29 Buy predictions and 3 Sell predictions.
As a result the target price of €37.00 shows a positive potential of 25.212% compared to the current price of €29.55 for Evotec AG.
For the coming years our community has positive and negative things to say abot the Evotec AG stock. Criterium "Revenue growth" gathered the most positive votes but regarding "Unique positioning" there were negative voices in the community.
What does Evotec do?

Pros and Cons of Evotec AG in the next few years

Pros
4
Revenue growth >5% per year expected
3
Medium risks for its business
3
Fair valuation
Cons
1
Few uniques
1
Risky balance sheet
Opinions by others
Your Opinion
Legal notice

Performance of Evotec AG vs. its peers

Security Change (%) 1w 1m 1y YTD 3y 5y
Evotec AG -3.790% -8.030% -10.940% 35.055% -1.958% 106.643% 803.946%
MorphoSys AG 1.060% -1.750% -15.331% -17.086% -12.641% 3.224% 97.646%
Nektar Therapeutics -3.640% -0.415% 11.804% 7.452% 26.000% - -
Ionis Pharmaceuticals Inc. 3.120% 2.062% -11.322% -6.954% -4.835% 3.772% 16.399%

Comments

Buy Evotec AG

Trip 
0
Report Share
19.01.21 Buy 3.18%

Sell Evotec AG

OldOrangeEyes 
0
Report Share
07.01.21 Sell 2.93%

Buy Evotec AG

Judge 
1
Report Share
09.11.20 Buy 21.35%
Show more
Not a member yet? Sign up for free!

Other discussions about Evotec AG Stock

Trading Evotec AG

Trading Evotec AG

NightTrain
19.02.20
New thread Forum

News

DGAP-News: EVOTEC AND RAPPTA THERAPEUTICS ENTER DISCOVERY AND DEVELOPMENT PARTNERSHIP FOCUSED ON ONCOLOGY TARGET: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: EVOTEC AND RAPPTA THERAPEUTICS ENTER DISCOVERY AND DEVELOPMENT PARTNERSHIP FOCUSED ON ONCOLOGY TARGET
DGAP-News: EVOTEC AND RAPPTA THERAPEUTICS ENTER DISCOVERY AND DEVELOPMENT PARTNERSHIP FOCUSED ON ONCOLOGY TARGET
eqs_en 
0 24.11.20
DGAP-News: EVOTEC PRESENTS GROWTH DRIVERS OF 'AUTOBAHN TO CURES' AT CAPITAL MARKETS DAY: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: EVOTEC PRESENTS GROWTH DRIVERS OF 'AUTOBAHN TO CURES' AT CAPITAL MARKETS DAY
DGAP-News: EVOTEC PRESENTS GROWTH DRIVERS OF 'AUTOBAHN TO CURES' AT CAPITAL MARKETS DAY
eqs_en 
0 19.11.20
DGAP-News: EVOTEC AND STORM THERAPEUTICS LEVERAGE INDIGO PLATFORM TO PROGRESS ONCOLOGY PROJECT TOWARDS CLINICAL STUDIES: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: EVOTEC AND STORM THERAPEUTICS LEVERAGE INDIGO PLATFORM TO PROGRESS ONCOLOGY PROJECT TOWARDS CLINICAL STUDIES
DGAP-News: EVOTEC AND STORM THERAPEUTICS LEVERAGE INDIGO PLATFORM TO PROGRESS ONCOLOGY PROJECT TOWARDS CLINICAL STUDIES
eqs_en 
0 17.11.20